Respiratory effects of β-blocker therapy in heart failure

Cardiovascular Drugs and Therapy

Volumn 23, Issue 5, 2009, Pages 377-384

  Agostoni, Piergiuseppe ^a,b   Palermo, Pietro ^a   Contini, Mauro ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Beta blockers; Exercise; Heart failure; Lung diffusion

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISOPROLOL; BUCINDOLOL; CARBON MONOXIDE; CARVEDILOL; METOPROLOL; NEBIVOLOL; PLACEBO;

AIRWAY; ALTITUDE; CLINICAL TRIAL; DRUG DOSE TITRATION; DRUG EFFECT; DRUG MECHANISM; EXERCISE; GAS EXCHANGE; HEART FAILURE; HUMAN; HYPERVENTILATION; HYPOXIA; KINETICS; LUNG ALVEOLUS CELL; LUNG DIFFUSION; LUNG FUNCTION; LUNG MECHANICS; OXYGEN TENSION; PRIORITY JOURNAL; QUALITY OF LIFE; RESPIRATORY FUNCTION; REST; REVIEW; SIDE EFFECT; SODIUM TRANSPORT; SPIROMETRY;

ADRENERGIC BETA-ANTAGONISTS; EXERCISE; HEART FAILURE; HUMANS; LUNG; RESPIRATORY MECHANICS;

EID: 72849111295     PISSN: 09203206     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10557-009-6195-2     Document Type: Review

References (64)

1. TP Chua AJ Coats 1995 The lungs in chronic heart failure Eur Heart J 16 882 887 1:STN:280:DyaK28%2FotFWrtw%3D%3D 7498200
2. RS Wright MS Levine PE Bellamy, et al. 1990 Ventilatory and diffusion abnormalities in potential heart transplant recipients Chest 98 816 820 10.1378/chest.98.4.816 1:STN:280:DyaK3M%2FgsFeqsQ%3D%3D 2209136
3. P Agostoni G Cattadori M Guazzi P Palermo M Bussotti G Marenzi 2000 Cardiomegaly as a possible cause of lung dysfunction in patients with heart failure Am Heart J 140 e24 10.1067/mhj.2000.110282 1:STN:280: DC%2BD28rgtFWgsw%3D%3D 11054632
4. K Wasserman YY Zhang A Gitt, et al. 1997 Lung function and exercise gas exchange in chronic heart failure Circulation 96 2221 2227 1:STN:280: DyaK2svnslWgsg%3D%3D 9337193 (Pubitemid 27425826)
5. P Agostoni M Bussotti G Cattadori, et al. 2006 Gas diffusion and alveolar-capillary unit in chronic heart failure Eur Heart J 27 2538 2543 10.1093/eurheartj/ehl302 17028107 (Pubitemid 44627297)
6. PG Agostoni GC Marenzi M Pepi, et al. 1993 Isolated ultrafiltration in moderate congestive heart failure J Am Coll Cardiol 21 424 431 1:STN:280:DyaK3s7kslersw%3D%3D 8426008 (Pubitemid 23047927)
7. P Agostoni G Marenzi G Lauri, et al. 1994 Sustained improvement in functional capacity after removal of body fluid with isolated ultrafiltration in chronic cardiac insufficiency: failure of furosemide to provide the same result Am J Med 96 191 199 10.1016/0002-9343(94)90142-2 1:CAS:528:DyaK2MXpsVWgsLg%3D 8154506
8. DP Francis W Shamim LC Davies, et al. 2000 Cardiopulmonary exercise testing for prognosis in chronic heart failure: continuous and independent prognostic value from VE/VCO(2)slope and peak VO(2) Eur Heart J 21 154 161 10.1053/euhj.1999.1863 1:STN:280:DC%2BD3c7gsFalug%3D%3D 10637089
9. TP Chua P Ponikowski D Harrington, et al. 1997 Clinical correlates and prognostic significance of the ventilatory response to exercise in chronic heart failure J Am Coll Cardiol 29 1585 1590 10.1016/S0735-1097(97)00078-8 1:STN:280:DyaK2szitl2htQ%3D%3D 9180123 (Pubitemid 27272454)
10. FX Kleber G Vietzke KD Wernecke, et al. 2000 Impairment of ventilatory efficiency in heart failure: prognostic impact Circulation 101 2803 2809 1:STN:280:DC%2BD3czhvVGnug%3D%3D 10859285
11. R Arena J Myers J Abella, et al. 2007 Development of a ventilatory classification system in patients with heart failure Circulation 115 2410 2417 10.1161/CIRCULATIONAHA.107.686576 17452607 (Pubitemid 46717963)
12. BD Johnson KC Beck LJ Olson, et al. 2000 Ventilatory constraints during exercise in patients with chronic heart failure Chest 117 321 332 10.1378/chest.117.2.321 1:STN:280:DC%2BD3c7jsFOrsw%3D%3D 10669670
13. P Agostoni R Pellegrino C Conca JR Rodarte V Brusasco 2002 Exercise hyperpnea in chronic heart failure: relationships to lung stiffness and expiratory flow limitation J Appl Physiol 92 1409 1416 11896004
14. S Puri BL Baker DP Dutka CM Oakley JM Hughes JG Cleland 1995 Reduced alveolar-capillary membrane diffusing capacity in chronic heart failure. Its pathophysiological relevance and relationship to exercise performance Circulation 91 2769 2774 1:STN:280:DyaK2M3nsl2hug%3D%3D 7758183
15. YC Huang MJ Helms NR MacIntyre 1994 Normal values for single exhalation diffusing capacity and pulmonary capillary blood flow in sitting, supine positions, and during mild exercise Chest 105 501 508 10.1378/chest.105.2.501 1:STN:280:DyaK2c7jvFCisw%3D%3D 8306754
16. FJ Roughton RE Forster 1957 Relative importance of diffusion and chemical reaction rates in determining rate of exchange of gases in the human lung, with special reference to true diffusing capacity of pulmonary membrane and volume of blood in the lung capillaries J Appl Physiol 11 290 302 1:CAS:528: DyaG1cXjs1ehsw%3D%3D 13475180
17. M Guazzi G Pontone R Brambilla P Agostoni G Reina 2002 Alveolar capillary membrane gas conductance: a novel prognostic indicator in chronic heart failure Eur Heart J 23 467 476 10.1053/euhj.2001.2803 1:STN:280:DC%2BD387ivVKmsg%3D%3D 11863349 (Pubitemid 35204186)
18. M Guazzi G Marenzi M Alimento M Contini P Agostoni 1997 Improvement of alveolar-capillary membrane diffusing capacity with enalapril in chronic heart failure and counteracting effect of aspirin Circulation 95 1930 1936 1:CAS:528:DyaK2sXislalur0%3D 9107182
19. P Agostoni A Magini D Andreini, et al. 2005 Spironolactone improves lung diffusion in chronic heart failure Eur Heart J 26 159 164 10.1093/eurheartj/ ehi023 1:CAS:528:DC%2BD2MXksFGgu7o%3D 15618072 (Pubitemid 40282784)
20. A Koike K Wasserman DK McKenzie S Zanconato D Weiler-Ravell 1990 Evidence that diffusion limitation determines oxygen uptake kinetics during exercise in humans J Clin Invest 86 1698 1706 10.1172/JCI114894 1:STN:280: DyaK3M%2Fls1WktA%3D%3D 2122982
21. PG Agostoni M Bussotti P Palermo M Guazzi 2002 Does lung diffusion impairment affect exercise capacity in patients with heart failure? Heart 88 453 459 10.1136/heart.88.5.453 1:STN:280:DC%2BD38nisVWguw%3D%3D 12381630
22. EG Abinader DS Sharif E Goldhammer 1999 Effects of low altitude on exercise performance in patients with congestive heart failure after healing of acute myocardial infarction Am J Cardiol 83 383 387 10.1016/S0002-9149(98)00873- X 1:STN:280:DyaK1M7ntVCntg%3D%3D 10072228 (Pubitemid 29066498)
23. C Van Laethem N Van De Veire G De Backer, et al. 2007 Response of the oxygen uptake efficiency slope to exercise training in patients with chronic heart failure Eur J Heart Fail 9 625 629 10.1016/j.ejheart.2007.01.007 17347033 (Pubitemid 46705567)
24. C Van Laethem N Van de Veire J De Sutter, et al. 2006 Prospective evaluation of the oxygen uptake efficiency slope as a submaximal predictor of peak oxygen uptake in aged patients with ischemic heart disease Am Heart J 152 297.e9 297.e15 10.1016/j.ahj.2006.04.032 (Pubitemid 44109828)
25. Harris P, Heath D. The Human pulmonary circulation. Edinburgh, London, Melburne, New York Churchill Livingstone; 1986. p. 329-44.
26. PG Agostoni M Guazzi M Bussotti M Grazi P Palermo G Marenzi 2000 Lack of improvement of lung diffusing capacity following fluid withdrawal by ultrafiltration in chronic heart failure J Am Coll Cardiol 36 1600 1604 10.1016/S0735-1097(00)00929-3 1:STN:280:DC%2BD3M%2FnsVGltw%3D%3D 11079664 (Pubitemid 30825995)
27. P Agostoni G Cattadori M Bianchi K Wasserman 2003 Exercise-induced pulmonary edema in heart failure Circulation 108 2666 2671 10.1161/01.CIR. 0000097115.61309.59 14581402 (Pubitemid 37466809)
28. G Cattadori K Wasserman C Meloni, et al. 2009 Alveolar membrane conductance decreases as BNP increases during exercise in heart failure. Rationale for BNP in the evaluation of dyspnea J Card Fail 15 136 144 10.1016/j.cardfail.2008.10.002 1:CAS:528:DC%2BD1MXisFOhsLo%3D 19254673
29. CG De Pasquale LF Arnolda IR Doyle PE Aylward DP Chew AD Bersten 2004 Plasma surfactant protein-B: a novel biomarker in chronic heart failure Circulation 110 1091 1096 10.1161/01.CIR.0000140260.73611.FA 15302797 (Pubitemid 39319007)
30. CG De Pasquale LF Arnolda IR Doyle RL Grant PE Aylward AD Bersten 2003 Prolonged alveolocapillary barrier damage after acute cardiogenic pulmonary edema Crit Care Med 31 1060 1067 10.1097/01.CCM.0000059649.31659.22 12682473 (Pubitemid 36444414)
31. CG De Pasquale LF Arnolda IR Doyle PE Aylward AE Russell AD Bersten 2005 Circulating surfactant protein-B levels increase acutely in response to exercise-induced left ventricular dysfunction Clin Exp Pharmacol Physiol 32 622 627 10.1111/j.0305-1870.2005.04241.x 16120188 (Pubitemid 41025823)
32. D Magrì M Brioschi C Banfi, et al. 2009 Circulating plasma surfactant protein type B as biological marker of alveolar-capillary barrier damage in chronic heart failure Circ Heart Fail 2 175 180 10.1161/ CIRCHEARTFAILURE.108.819607 19808337
33. FS Cole 2003 Surfactant protein B: unambiguously necessary for adult pulmonary function Am J Physiol Lung Cell Mol Physiol 285 L540 L542 1:CAS:528:DC%2BD3sXnsVGmu7Y%3D 12902317
34. Serrano AG, Perez-Gil J. Protein-lipid interaction and surface activity in the pulmonary surfactant system. Chem Phys Lip. 2006;141:105-18.
35. F Waagstein MR Bristow K Swedberg, et al. 1993 Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group Lancet 342 1441 1446 10.1016/0140- 6736(93)92930-R 1:STN:280:DyaK2c%2Fms1Kisw%3D%3D 7902479 (Pubitemid 24000287)
36. CIBIS Investigators and Committees 1994 A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS) Circulation 90 1765 1773
37. Australia/New Zealand Heart Failure Research Collaborative Group 1997 Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease Lancet 349 375 380 10.1016/S0140-6736(97)80008-6 (Pubitemid 27077664)
38. M Packer MR Bristow JN Cohn, et al. 1996 The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group N Engl J Med 334 1349 1355 10.1056/NEJM199605233342101 1:CAS:528:DyaK28Xjs1Wjtbw%3D 8614419 (Pubitemid 26152713)
39. MERIT-HF Study Group 1999 Effect of metoprolol CR/XL in chronic heart failure: Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Lancet 353 2001 2007 10.1016/S0140-6736(99)04440-2 (Pubitemid 29271744)
40. The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet 1999; 353:9-13.
41. M Packer AJ Coats MB Fowler, et al. 2001 Effect of carvedilol on survival in severe chronic heart failure N Engl J Med 344 1651 1658 10.1056/ NEJM200105313442201 1:CAS:528:DC%2BD3MXkslWjt7c%3D 11386263 (Pubitemid 32479962)
42. HJ Dargie 2001 Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial Lancet 357 1385 1390 10.1016/S0140-6736(00)04560-8 1:CAS:528:DC%2BD3MXjsFWntro%3D 11356434 (Pubitemid 32455364)
43. PA Poole-Wilson K Swedberg JG Cleland, et al. 2003 Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial Lancet 362 7 13 10.1016/S0140-6736(03)13800-7 1:CAS:528:DC%2BD3sXltF2isrs%3D 12853193 (Pubitemid 36835815)
44. E Eichhorn M Domanski H Krause-Steinrauf J Anderson K Boardman M Bristow 2001 A trial of the beta-blocker bucindolol in patients with advanced chronic heart failure N Engl J Med 344 1659 1667 10.1056/NEJM200105313442202 1:CAS:528:DC%2BD3MXkslWjtb4%3D (Pubitemid 32479963)
45. MD Flather MC Shibata AJ Coats, et al. 2005 Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS) Eur Heart J 26 215 225 10.1093/eurheartj/ehi115 1:CAS:528:DC%2BD2MXksFCgtbc%3D 15642700 (Pubitemid 40222359)
46. M Bristow P Nelson W Minobe C Johnson 2005 Characterization of β1-adrenergic receptor selectivity of nebivolol and various other beta-blockers in human myocardium Am J Hypertens 18 A51 A52 10.1016/j.amjhyper. 2005.03.139
47. RP Mason L Kalinowski RF Jacob AM Jacoby T Malinski 2005 Nebivolol reduces nitroxidative stress and restores nitric oxide bioavailability in endothelium of black Americans Circulation 112 3795 3801 10.1161/CIRCULATIONAHA. 105.556233 1:CAS:528:DC%2BD2MXht1yitb7O 16330685 (Pubitemid 43739521)
48. A Maffei C Vecchione A Aretini, et al. 2006 Characterization of nitric oxide release by nebivolol and its metabolites Am J Hypertens 19 579 586 10.1016/j.amjhyper.2005.09.021 1:CAS:528:DC%2BD28XltFOks7c%3D 16733229 (Pubitemid 43775847)
49. HD Schultz YL Li 2007 Carotid body function in heart failure Respir Physiol Neurobiol 157 171 185 10.1016/j.resp.2007.02.011 1:CAS:528: DC%2BD2sXkslKqtr4%3D 17374517 (Pubitemid 46617445)
50. K Wasserman BJ Whipp SN Koyal MG Cleary 1975 Effect of carotid body resection on ventilatory and acid-base control during exercise J Appl Physiol 39 354 358 1:STN:280:DyaE28%2FisVOnsQ%3D%3D 240799
51. P Ponikowski TP Chua SD Anker, et al. 2001 Peripheral chemoreceptor hypersensitivity: an ominous sign in patients with chronic heart failure Circulation 104 544 549 10.1161/hc3101.093699 1:STN:280:DC%2BD3MvjtFGksw%3D%3D 11479251
52. P Agostoni M Contini A Magini, et al. 2006 Carvedilol reduces exercise-induced hyperventilation: a benefit in normoxia and a problem with hypoxia Eur J Heart Fail 8 729 735 10.1016/j.ejheart.2006.02.001 1:CAS:528:DC%2BD28XhtFentbzE 16533619 (Pubitemid 44637272)
53. P Agostoni M Guazzi M Bussotti S De Vita P Palermo 2002 Carvedilol reduces the inappropriate increase of ventilation during exercise in heart failure patients Chest 122 2062 2067 10.1378/chest.122.6.2062 1:CAS:528:DC%2BD3sXlsF2gsg%3D%3D 12475848 (Pubitemid 36054183)
54. M Valentini M Revera G Caldara, et al. 2008 Effects of selective and non selective beta-blockers on exercise performance under hypobaric hypoxia at high altitude J Hypertension 26 S270
55. T Kinugawa Y Tomikura K Ogino, et al. 2002 Relation between neurohormonal activation and enhanced ventilatory response to exercise in patients with chronic congestive heart failure Am J Cardiol 89 604 607 10.1016/S0002-9149(01) 02306-2 1:CAS:528:DC%2BD38XhsFWnsr0%3D 11867051 (Pubitemid 34178577)
56. P Agostoni M Contini G Cattadori, et al. 2007 Lung function with carvedilol and bisoprolol in chronic heart failure: is beta selectivity relevant? Eur J Heart Fail 9 827 833 10.1016/j.ejheart.2007.04.006 1:CAS:528:DC%2BD2sXovFentbc%3D 17561440 (Pubitemid 47212829)
57. R Wolk BD Johnson VK Somers, et al. 2005 Effects of beta-blocker therapy on ventilatory responses to exercise in patients with heart failure J Card Fail 11 333 339 10.1016/j.cardfail.2004.11.008 1:CAS:528:DC%2BD2MXltVarurs%3D 15948082
58. KK Witte S Thackray NP Nikitin JG Cleland AL Clark 2005 The effects of long-term beta-blockade on the ventilatory responses to exercise in chronic heart failure Eur J Heart Fail 7 612 617 10.1016/j.ejheart.2004.05.006 1:CAS:528:DC%2BD2MXks1emtbw%3D 15921802 (Pubitemid 40732994)
59. M Kataoka T Satoh T Yoshikawa, et al. 2008 Comparison of the effects of carvedilol and metoprolol on exercise ventilatory efficiency in patients with congestive heart failure Circ J 72 358 363 10.1253/circj.72.358 1:CAS:528:DC%2BD1cXktVSgt78%3D 18296829 (Pubitemid 351600626)
60. Wasserman K, Hansen JE, Sue DY. Principles of exercise testing and interpretation. 3rd ed. Baltimore: Lippincott Williams & Wilkins; 1999. p. 10-61.
61. P Agostoni M Valentini D Magri, et al. 2008 Disappearance of isocapnic buffering period during increasing work rate exercise at high altitude Eur J Cardiovasc Prev Rehabil 15 354 358 10.1097/HJR.0b013e3282f62982 18525393
62. M Bussotti D Magri E Previtali, et al. 2008 End-tidal pressure of CO2 and exercise performance in healthy subjects Eur J Appl Physiol 103 727 732 10.1007/s00421-008-0773-z 1:CAS:528:DC%2BD1cXpt1Cqs7o%3D 18521623
63. KK Witte AL Clark 2005 Beta-blockers and inspiratory pulmonary function in chronic heart failure J Card Fail 11 112 116 10.1016/j.cardfail.2004.07.007 1:CAS:528:DC%2BD2MXhslWrs7s%3D 15732030 (Pubitemid 40269785)
64. P Bartsch M Maggiorini M Ritter C Noti P Vock O Oelz 1991 Prevention of high-altitude pulmonary edema by nifedipine N Engl J Med 325 1284 1289 1:STN:280:DyaK38%2FhvVSmtg%3D%3D 1922223